World's First Zika Virus Vaccine Made in India Updated: September 18, 2020 Published: 2016-02-03



(eNews.pk) - In such an important moment "Making India", scientists in a laboratory in Hyderabad say they have developed the world's first vaccine against the virus Zika. They say, in fact, they have two.



The World Health Organization has declared Zika and his alleged link with birth defects a global health emergency. More than 20 countries in Latin America have reported an outbreak and a rare case the Zika virus transmitted through sex has been reported in Texas, USA ..



As the world seeks a vaccine and other global companies take first steps in research, Bharat Biotech International Limited in Hyderabad says Zika has patented the vaccine.



"In Zika, probably we are the first company of the vaccine in the world to introduce a vaccine candidate patent about nine months ago," said Dr. Krishna Ella, President and CEO, Bharat Biotech Ltd.



The use of a live virus Zika officially imported Hyderabad company has developed two vaccine candidates, but taking them through trials in animals and humans could be a long haul. Dr She said she had sought government support in this and the Indian Council of Medical Research (ICMR) has stepped forward to help.



"We have just been informed about the candidate Zika vaccine Bharat Biotech has. Let's look from a scientific point of view and see the feasibility of carrying on. It's a good example of a brand in India of products," said Dr .. Soumya Swaminathan, a pediatrician and director general, ICMR.



Dr. She told a best your company can make a million doses of vaccine within four months. It has sought direct intervention of Prime Minister Narendra Modi to ensure the development and delivery of the vaccine is the fast track, cutting through the bureaucracy of regulatory approvals, noting that the vaccine can help countries like Brazil, another member of the BRICS (Brazil, Russia, India, China and South Africa) group.



Experts have praised the foresight of Bharat Biotech in working on a vaccine well ahead in a forgotten disease that has now taken epidemic proportions worldwide. In such an important moment "Making India", scientists in a laboratory in Hyderabad say they have developed the world's first vaccine against the virus Zika. They say, in fact, they have two.



The World Health Organization has declared Zika and his alleged link with birth defects a global health emergency. More than 20 countries in Latin America have reported an outbreak and a rare case the Zika virus transmitted through sex has been reported in Texas, USA ..



As the world seeks a vaccine and other global companies take first steps in research, Bharat Biotech International Limited in Hyderabad says Zika has patented the vaccine.



"In Zika, probably we are the first company of the vaccine in the world to introduce a vaccine candidate patent about nine months ago," said Dr. Krishna Ella, President and CEO, Bharat Biotech Ltd.



The use of a live virus Zika officially imported Hyderabad company has developed two vaccine candidates, but taking them through trials in animals and humans could be a long haul. Dr She said she had sought government support in this and the Indian Council of Medical Research (ICMR) has stepped forward to help.



"We have just been informed about the candidate Zika vaccine Bharat Biotech has. Let's look from a scientific point of view and see the feasibility of carrying on. It's a good example of a brand in India of products," said Dr .. Soumya Swaminathan, a pediatrician and director general, ICMR.



Dr. She told a best your company can make a million doses of vaccine within four months. It has sought direct intervention of Prime Minister Narendra Modi to ensure the development and delivery of the vaccine is the fast track, cutting through the bureaucracy of regulatory approvals, noting that the vaccine can help countries like Brazil, another member of the BRICS (Brazil, Russia, India, China and South Africa) group.



Experts have praised the foresight of Bharat Biotech in working on a vaccine well ahead in a forgotten disease that has now taken epidemic proportions worldwide.























